Table 4.
Summary of multivariable logistic regression analyses for outcome variables
| Symptom present | p value | Patient-reported pain present | p value | Clinical finding present | p value | Clinically observed disturbance of mandibular movement present | p value | |
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| Type of JIA | ||||||||
| Oligoarthritis | 2.29 (0.64, 8.17) | 0.203 | 2.83 (0.78, 10.29) | 0.115 | 1.15 (0.12, 11.00) | 0.902 | 1.64 (0.41, 6.57) | 0.483 |
| Seronegative polyarthritis | ref | ref | ref | ref | ||||
| Sex | ||||||||
| Girls | 3.37 (0.69, 16.42) | 0.133 | 2.80 (0.58, 13.62) | 0.202 | ref | ref | ||
| Boys | ref | ref | 1.03 (0.05, 21.91) | 0.983 | 1.18 (0.22, 6.36) | 0.846 | ||
| Age group at diagnosis of JIA (years) | ||||||||
| < 5.3 | ref | ref | ref | ref | ||||
| ≥ 5.3 | 1.28 (0.41, 3.99) | 0.677 | 1.72 (0.54, 5.44) | 0.356 | 3.97 (0.31, 50.79) | 0.289 | 1.69 (0.49, 6.34) | 0.440 |
| Delay from diagnosis of JIA to diagnosis of TMJ symptoms and/or signs (weeks) | ||||||||
| < 33.0 | 1.26 (0.36, 4.50) | 0.718 | 1.19 (0.33, 4.30) | 0.792 | 5.68 (0.38, 85.47) | 0.209 | 2.19 (0.53, 9.02) | 0.279 |
| ≥ 33.0 | ref | ref | ref | ref | ||||
| Anti-nuclear antibody (ANA)a | ||||||||
| Positive | ref | ref | 1.77 (0.11, 28.09) | 0.685 | 3.43 (0.79, 14.81) | 0.099 | ||
| Negative | 4.88 (1.29, 18.41) | 0.019 | 4.56 (1.21, 17.19) | 0.025 | ref | ref | ||
| Human leucocyte antigen B27 (HLA-B27)b | ||||||||
| Positive | 1.09 (0.29, 4.10) | 0.894 | 1.33 (0.35, 5.13) | 0.680 | ref | ref | ||
| Negative | ref | ref | 7.22 (0.57, 90.85) | 0.126 | 1.23 (0.25, 6.08) | 0.798 | ||
| Medication at the time of TMJ involvement | ||||||||
| Yes | 1.73 (0.34, 8.71) | 0.508 | 1.53 (0.29, 7.99) | 0.615 | NA | ref | ||
| No | ref | ref | 2.12 (0.19, 23.22) | 0.537 |
aMissing n = 0
bMissing n = 3
JIA juvenile idiopathic arthritis
TMJ temporomandibular joint
OR odds ratio
CI confidence interval
NA Not applicable
ref reference